N
Nurix
Biotech & Life Sciences · San Francisco, United States · Founded 2012 · IPO 2020
Develops small molecule inhibitors for the treatment of proliferative and degenerative diseases MoreLess
Nurix Therapeutics is a biotechnology company focused on discovering and developing drugs that harness the natural process of protein degradation to treat a wide range of diseases. The company's core technology revolves around controlling ubiquitin E3 ligases, which are key enzymes responsible for protein breakdown in human cells. By targeting these enzymes, Nurix aims to develop novel therapeutic agents, particularly in the field of oncology, including small molecule immuno-oncology agents.
Nurix operates in the biopharmaceutical market, primarily serving patients with cancer and other serious diseases. The company employs a business model that involves drug discovery and development, with revenue generated through partnerships, licensing agreements, and potential future sales of its proprietary drugs.
Keywords: biotechnology, protein degradation, ubiquitin E3 ligases, oncology, immuno-oncology, drug discovery, therapeutic agents, cancer treatment, biopharmaceutical, small molecules.
Talent graph
Nurix's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Nurix has talent and traffic
team presence
across markets
Patent intelligence
$31M patent portfolio · 38 active families
Where Nurix concentrates vs peers
Each axis is a top-10 topic across Nurix and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Nurix
An AI-synthesized read of the highest-engagement posts about Nurix on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nurix on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.